Innovent Biologics’ Sycume Approved by China’s NMPA for Thyroid Eye Disease
China-based Innovent Biologics Inc. (HKG: 1801) announced that its New Drug Application (NDA) for Sycume...
Simcere Pharmaceutical’s ADC189 NDA Accepted for Influenza Treatment
Simcere Pharmaceutical Group Limited (HKG: 2096) and AnDiConBio announced that the New Drug Application (NDA)...
Rona Therapeutics Secures $25M Pre-B Round to Advance siRNA Therapies
Shanghai-based Rona Therapeutics announced the successful completion of a $25 million (RMB 180 million) Pre-B...
Tonghua Golden-Horse Pharmaceutical Embraces AI with DeepSeek R1 for Drug Innovation
Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (SHE: 000766) recently held a special meeting to deploy...
DeepSeek’s Rise in the Pharmaceutical Industry: A New Era of AI-Driven Transformation
The emergence of DeepSeek-R1 during the Lunar New Year celebrations marked a pivotal moment in...
Pharmavan and Kefeng Changjian Sign Pact to Accelerate SPT-07A Development
Suzhou Pharmavan Co., Ltd. has announced plans to enter into a cooperation agreement with Sichuan...
Roche’s Itovebi Approved in China for PIK3CA-Mutated Breast Cancer
Itovebi (inavolisib), a best-in-class PI3Kα inhibitor from Swiss giant Roche (SWX: ROG, OTCMKTS: RHHBY), has...
Quantum Hi-Tech and ECNU Establish AI-Driven Drug Manufacturing Lab
CRO+CDMO Quantum Hi-Tech (China) Biotechnology Co., Ltd (ChemPartner, SHE: 300149) announced plans to establish an...
BioCity and MSD Enter Clinical Collaboration for BC3195 and Keytruda Combination Trial
China-based BioCity Biopharmaceutics Co., Ltd. announced a clinical collaboration agreement with US-based giant Merck, Sharp...
Shanghai Fosun Pharmaceutical Transfers Unicorn II Holdings Stake to Warburg Pincus Subsidiary
China-based Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) announced plans to transfer...
Salipro Biotech and Boehringer Ingelheim Collaborate on Drug Development for Membrane Proteins
Sweden-based Salipro Biotech AB announced a research and license agreement with German pharmaceutical giant Boehringer...
CSPC Pharmaceutical Group Receives FDA Approval for SYH2051 Clinical Trial
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) announced receiving approval from the US Food and...
Gaush Meditech’s ANTERION Ophthalmic Detector Receives NMPA Market Approval
Suzhou-based Gaush Meditech Ltd (HKG: 2407) announced receiving market approval from the National Medical Products...
Bio-Thera Solutions’ BAT2506 Biosimilar Accepted for Review by China’s NMPA
China-based Bio-Thera Solutions Inc. (SHA: 688177) announced that a market filing for its BAT2506, a...
Otsuka and Lundbeck Win EU Approval for Rxulti in Adolescent Schizophrenia
Japan-based Otsuka Pharmaceutical Co., Ltd and its Danish partner Lundbeck A/S (OTCMKTS: HLUBF) jointly announced...
Shanghai Fosun Pharmaceutical Gains NMPA Approval for XH-S003 in PNH Treatment
China-based Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) announced receiving clinical trial...
Trinomab Biotech Launches Xintituo for Tetanus Treatment in Zhuhai
China-based Trinomab Biotech Co., Ltd announced the first delivery of its antitetanus toxin monoclonal antibody...
Tasly Pharma’s NR-20201 Receives NMPA Approval for Acute Ischemic Stroke Trial
China-based Tasly Pharma Co., Ltd (SHA: 600535) announced receiving approval from the National Medical Products...
Jiangsu Aidea’s AD108 Receives NMPA Approval for Acute Ischemic Stroke
China’s Jiangsu Aidea Pharmaceutical Co., Ltd (SHA: 688488) announced receiving clinical approval from the National...
Insilico Medicine Closes USD110 Million Series E Round to Advance AI-Driven Drug Pipeline
China’s generative artificial intelligence (AI)-driven biotech Insilico Medicine announced the completion of a USD110 million...